Abingdon Health (LON:ABDX) Releases Quarterly Earnings Results

Abingdon Health (LON:ABDX) issued its quarterly earnings results on Tuesday. The company reported GBX (0.51) EPS for the quarter, Digital Look Earnings reports. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.

Abingdon Health Stock Performance

ABDX traded down GBX 0.85 during midday trading on Wednesday, reaching GBX 8.65. The company had a trading volume of 350,495 shares, compared to its average volume of 236,617. Abingdon Health has a 12-month low of GBX 5.50 and a 12-month high of GBX 13. The business has a 50-day moving average price of GBX 10.74 and a two-hundred day moving average price of GBX 10.52. The stock has a market cap of £21.86 million, a PE ratio of -10.68 and a beta of 0.13. The company has a debt-to-equity ratio of 15.05, a quick ratio of 1.96 and a current ratio of 1.91.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.